Has Michael Oglesbay, DO received payments from drug or device companies?

Yes. Drug and device makers reported $1,356 in general payments to Michael Oglesbay, DO across 70 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Oglesbay, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Oglesbay, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Oglesbay, DO

Family Medicine · Post Falls, IDNPI 1659476844

Payments from drug & device makers

$1,356in general payments, 2019–2025

Across 70 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$605
Lilly USA, LLC$179
Novo Nordisk$165
AbbVie$142
Amgen$103
Antares Pharma, Inc.$49
plus $113 from 6 others

What the payments were for

Food & beverage$1,356100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	27	$605
Lilly USA, LLC	10	$179
Novo Nordisk	10	$165
AbbVie(2 entities)	8	$142
Amgen	5	$103
Antares Pharma, Inc.	3	$49
Phadia US Inc.	2	$26
Eisai Inc.	1	$24
Hologic Sales And Service, LLC	1	$22
Bayer	1	$18
Lundbeck LLC	1	$14
Therapeuticsmd, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FARXIGA$111

How this compares

$1,356 in reported general payments places this provider in the 75th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho →

Medicare billing

Part B allowed, 2024

$22,575

Medicare patients

Services billed

192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Liothyronine Sodium	39	$2,548
Np ThyroidThyroid,pork	16	$1,545
Levothyroxine Sodium	146	$1,380
Testosterone Cypionate	16	$847
ProgesteroneProgesterone, Micronized	11	$699
Atorvastatin Calcium	16	$133
Anastrozole	23	$80
Donepezil Hcl	13	$67
Omeprazole	12	$13

Paid to pharmacies, not to this prescriber.